SCHEMBL9853427

SCHEMBL9853427

CSCCN1C(=O)c2ccccc2Oc2ncccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.48
HDAC3 O15379 1/20 0.45
TUBB4A P04350 1/20 0.45
TUBB P07437 1/20 0.45
TUBA3C P0DPH7 1/20 0.45
HDAC4 P56524 1/20 0.45
TUBA1B P68363 1/20 0.45
TUBA4A P68366 1/20 0.45
TUBB4B P68371 1/20 0.45
TUBB3 Q13509 1/20 0.45
HDAC1 Q13547 1/20 0.45
TUBB2A Q13885 1/20 0.45
TUBB8 Q3ZCM7 1/20 0.45
TUBA3E Q6PEY2 1/20 0.45
TUBA1A Q71U36 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
TUBA1C Q9BQE3 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8936600 0.84 HDAC3 (0.43) TP53HDAC3TUBB4ATUBBTUBA3C
SCHEMBL9853429 0.79 NR1H2 (0.47) TP53KMT2AMAPTLMNASMN1; SMN2
SCHEMBL9212981 0.79 TP53 (0.58) TP53KMT2AMAPTLMNASMN1; SMN2
SCHEMBL8936730 0.79 TP53 (0.53) TP53KMT2AMAPTALDH1A1MEN1
SCHEMBL8936648 0.79 TP53 (0.45) TP53HDAC3TUBB4ATUBBTUBA3C
SCHEMBL8936654 0.79 TP53 (0.45) TP53HDAC3TUBB4ATUBBTUBA3C
SCHEMBL8936630 0.77 TP53 (0.51) TP53KMT2AMAPTLMNAMEN1
SCHEMBL9099785 0.77 TP53 (0.56) TP53KMT2AMAPTLMNASMN1; SMN2
SCHEMBL9101435 0.76 TP53 (0.60) TP53KMT2AMAPTLMNASMN1; SMN2
SCHEMBL8936669 0.72 TP53 (0.46) TP53KMT2AMAPTLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0417534-A1 Pyrido[2,3-b][1,4]benzoxazepin (and thiazepin)-6(5H)-ones and thiones and their use in the prevention or treatment of AIDS Boehringer Ingelheim Pharmaceuticals Inc. (US) 1991-03-20 EP disclosed